Future Oncol. 2012;8(9):1135-1147. Follow-up, initiation, execution and tailoring of treatment in case of recurrence of ovarian cancer have to take into account evidence-based guidelines and the ...

“Several clinical trials have confirmed the role of hormone therapy in recurrent ovarian cancer treatment, especially in patients with low-grade tumors,” says review author Dr. Siqing ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical ...

The therapeutic landscape in recurrent ovarian cancer is characterized by well-established strategies, a number of concepts still lacking confirmation in prospective randomized trials and numerous ...